신경혈관내 코일 시장 규모, 점유율, 동향 분석 : 유형별, 용도별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Neuroendovascular Coil Market Size & Trends:

The global neuroendovascular coil market size was estimated at USD 1.04 billion in 2024 and is projected to grow at a CAGR of 6.5% from 2025 to 2030. This growth is attributed to the increasing incidence of cerebral aneurysms and strokes, fueled by aging populations and lifestyle-related risk factors such as hypertension, smoking, and diabetes.

Technological advancements have significantly enhanced procedural efficacy and safety, including developing next-generation detachable, hydrogel-coated, and 3D complex coils. According to the data by NIH 2025, each year, an estimated 795,000 people in the U.S. experience a stroke, with approximately 610,000 of these being first-time occurrences. Nearly one in four stroke survivors will suffer a subsequent stroke. Among all stroke cases, about 87% are classified as ischemic strokes, while the remaining 13% are hemorrhagic strokes.

The aging population significantly drives the neuroendovascular coil market due to the higher prevalence of neurological conditions, such as aneurysms, which are more common in older adults. As the elderly population grows, the demand for minimally invasive treatments, such as neuroendovascular coil embolization, increases, as these procedures are safer and involve quicker recovery than traditional surgery. Additionally, the higher risk of complications in older patients, such as aneurysms bursting or strokes, further boosts the demand for neuroendovascular coils. Healthcare systems worldwide are adapting to the needs of aging populations, increasing treatment resources, and creating favorable reimbursement policies, which helps expand the market. Moreover, the focus on improving the quality of life for elderly individuals enhances the demand for advanced, minimally invasive options such as neuroendovascular coils, contributing to the market's growth.

The below graph presents projected data on the proportion of the population aged 65 and older across various OECD countries by the year 2050, highlighting the global trend of population aging. Countries such as South Korea (39.8%), Japan (37.7%), and Italy (33.7%) are expected to have the highest percentages of elderly individuals, indicating rapid demographic shifts driven by increased life expectancy and declining birth rates. Additionally, it indicates a growing demand for age-related medical interventions and technologies, such as neuroendovascular coils, as the incidence of conditions such as stroke is expected to rise with the aging demographic.

Hypertension is one of the most significant risk factors for a variety of vascular diseases, including cerebral aneurysms, strokes, and other cerebrovascular abnormalities. Its growing prevalence globally is a critical factor driving the expansion of the neuroendovascular coil market. Neuroendovascular coils are widely used in the treatment of brain aneurysms and vascular malformations, which are caused or exacerbated by uncontrolled hypertension. Hypertension is the leading cause of hemorrhagic strokes. It contributes to the narrowing and hardening of arteries, making them more susceptible to blockage or rupture. Neuroendovascular procedures, including the use of coils, are a frontline treatment for hemorrhagic strokes caused by ruptured aneurysms. The increasing global burden of hypertension, especially in low- and middle-income countries where blood pressure control is insufficient, is expected to lead to a rise in stroke cases, thereby propelling the demand for neuroendovascular interventions. According to the British Heart Foundation BHF, 2025, it is estimated that around 30% of UK adults, approximately 16 million people, are living with high blood pressure, and up to half of them are not receiving effective treatment. While about 11 million individuals have been diagnosed by their general practitioner, this suggests that up to 5 million adults may remain undiagnosed. In total, up to 8 million people in the UK could be living with undiagnosed or uncontrolled high blood pressure.

Aneurysms in the brain, which occur when blood vessels weaken and form a bulge, are a significant concern among the aging population. The risk of aneurysms increases with age, particularly after age 50. As the number of elderly individuals rises globally, the occurrence of aneurysms has become more prevalent, fueling demand for treatment options. Neuroendovascular coils are one of the preferred methods for treating these aneurysms, as they involve less invasive techniques than traditional surgery, making them more suitable for elderly patients who may have other health concerns or are not candidates for more invasive procedures.

Global Neuroendovascular Coil Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global neuroendovascular coil market report based on type, application, end use, and region:

• Type Outlook (Revenue, USD Million, 2018 - 2030)
• Bare Platinum Coils
• Hydrogel-Coated Coils
• Application Outlook (Revenue, USD Million, 2018 - 2030)
• Cerebral Infarction
• Cerebral Aneurysm
• Arteriovenous Malformation (AVM)
• Others
• End Use Outlook (Revenue, USD Million, 2018 - 2030)
• Hospitals
• Ambulatory Surgery Centers
• Specialty Clinics
• Others
• Regional Outlook (Revenue, USD Million, 2018 - 2030)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Type
  • 1.2.2. Application
  • 1.2.3. End Use
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Neuroendovascular Coil Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising incidence of cerebral aneurysms and stroke
    • 3.2.1.2. Growing preference for minimally invasive procedures
    • 3.2.1.3. Technological advancements in coil design
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High cost of devices and procedures
    • 3.2.2.2. Risk of recurrence or incomplete occlusion
  • 3.2.3. Market Opportunities Analysis
    • 3.2.3.1. Expansion in emerging markets
  • 3.2.4. Market Challenges Analysis
    • 3.2.4.1. Regulatory and clinical trial complexities
• 3.3. Business Environment Analysis
  • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTLE Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Neuroendovascular Coil Market: Type Business Analysis

• 4.1. Type Market Share, 2024 & 2030
• 4.2. Type Segment Dashboard
• 4.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
• 4.4. Bare Platinum Coils
  • 4.4.1. Bare Platinum Coils Market, 2018 - 2030 (USD Million)
• 4.5. Hydrogel-Coated Coils
  • 4.5.1. Hydrogel-Coated Coils Market, 2018 - 2030 (USD Million)

Chapter 5. Neuroendovascular Coil Market: Application Business Analysis

• 5.1. Application Market Share, 2024 & 2030
• 5.2. Application Segment Dashboard
• 5.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 5.4. Cerebral Infarction
  • 5.4.1. Cerebral Infarction Market, 2018 - 2030 (USD Million)
• 5.5. Cerebral Aneurysm
  • 5.5.1. Cerebral Aneurysm Market, 2018 - 2030 (USD Million)
• 5.6. Arteriovenous Malformation (AVM)
  • 5.6.1. Arteriovenous Malformation (AVM) Market, 2018 - 2030 (USD Million)
• 5.7. Others
  • 5.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Neuroendovascular Coil Market: End Use Business Analysis

• 6.1. End Use Market Share, 2024 & 2030
• 6.2. End Use Segment Dashboard
• 6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 6.4. Hospital
  • 6.4.1. Hospitals Market, 2018 - 2030 (USD Million)
• 6.5. Ambulatory Surgery Centers
  • 6.5.1. Ambulatory Surgery Centers Market, 2018 - 2030 (USD Million)
• 6.6. Specialty Clinics
  • 6.6.1. Specialty Clinics Market, 2018 - 2030 (USD Million)
• 6.7. Others
  • 6.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Neuroendovascular Coil Market: Regional Estimates & Trend Analysis by Technology and End Use

• 7.1. Regional Market Share Analysis, 2024 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 7.4. North America
  • 7.4.1. North America Neuroendovascular Coil Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
  • 7.4.2. U.S.
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Regulatory Framework
    • 7.4.2.3. Competitive Insights
    • 7.4.2.4. U.S. Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.4.3. Canada
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Regulatory Framework
    • 7.4.3.3. Competitive Insights
    • 7.4.3.4. Canada Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.4.4. Mexico
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Regulatory Framework
    • 7.4.4.3. Competitive Insights
    • 7.4.4.4. Mexico Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 7.5. Europe
  • 7.5.1. Europe Neuroendovascular Coil Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
  • 7.5.2. UK
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Regulatory Framework
    • 7.5.2.3. Competitive Insights
    • 7.5.2.4. UK Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.3. Germany
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Regulatory Framework
    • 7.5.3.3. Competitive Insights
    • 7.5.3.4. Germany Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.4. France
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Regulatory Framework
    • 7.5.4.3. Competitive Insights
    • 7.5.4.4. France Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.5. Italy
    • 7.5.5.1. Key Country Dynamics
    • 7.5.5.2. Regulatory Framework
    • 7.5.5.3. Competitive Insights
    • 7.5.5.4. Italy Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.6. Spain
    • 7.5.6.1. Key Country Dynamics
    • 7.5.6.2. Regulatory Framework
    • 7.5.6.3. Competitive Insights
    • 7.5.6.4. Spain Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.7. Norway
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Regulatory Framework
    • 7.5.7.3. Competitive Insights
    • 7.5.7.4. Norway Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.8. Denmark
    • 7.5.8.1. Key Country Dynamics
    • 7.5.8.2. Regulatory Framework
    • 7.5.8.3. Competitive Insights
    • 7.5.8.4. Denmark Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.9. Sweden
    • 7.5.9.1. Key Country Dynamics
    • 7.5.9.2. Regulatory Framework
    • 7.5.9.3. Competitive Insights
    • 7.5.9.4. Sweden Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. Asia Pacific Neuroendovascular Coil Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
  • 7.6.2. Japan
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Regulatory Framework
    • 7.6.2.3. Competitive Insights
    • 7.6.2.4. Japan Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6.3. China
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Regulatory Framework
    • 7.6.3.3. Competitive Insights
    • 7.6.3.4. China Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6.4. India
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Regulatory Framework
    • 7.6.4.3. Competitive Insights
    • 7.6.4.4. India Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6.5. South Korea
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Regulatory Framework
    • 7.6.5.3. Competitive Insights
    • 7.6.5.4. South Korea Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6.6. Australia
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Regulatory Framework
    • 7.6.6.3. Competitive Insights
    • 7.6.6.4. Australia Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6.7. Thailand
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Regulatory Framework
    • 7.6.7.3. Competitive Insights
    • 7.6.7.4. Thailand Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 7.7. Latin America
  • 7.7.1. Latin America Neuroendovascular Coil Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
  • 7.7.2. Brazil
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Regulatory Framework
    • 7.7.2.3. Competitive Insights
    • 7.7.2.4. Brazil Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.7.3. Argentina
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Regulatory Framework
    • 7.7.3.3. Competitive Insights
    • 7.7.3.4. Argentina Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 7.8. MEA
  • 7.8.1. MEA Neuroendovascular Coil Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
  • 7.8.2. South Africa
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Regulatory Framework
    • 7.8.2.3. Competitive Insights
    • 7.8.2.4. South Africa Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.8.3. Saudi Arabia
    • 7.8.3.1. Key Country Dynamics
    • 7.8.3.2. Regulatory Framework
    • 7.8.3.3. Competitive Insights
    • 7.8.3.4. Saudi Arabia Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.8.4. UAE
    • 7.8.4.1. Key Country Dynamics
    • 7.8.4.2. Regulatory Framework
    • 7.8.4.3. Competitive Insights
    • 7.8.4.4. UAE Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.8.5. Kuwait
    • 7.8.5.1. Key Country Dynamics
    • 7.8.5.2. Regulatory Framework
    • 7.8.5.3. Competitive Insights
    • 7.8.5.4. Kuwait Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Participant Overview
• 8.2. Company Share Analysis, 2024
• 8.3. Company Categorization
• 8.4. Strategy Mapping
• 8.5. Company Profiles/Listing
  • 8.5.1. Penumbra, Inc
    • 8.5.1.1. Overview
    • 8.5.1.2. Financial Performance
    • 8.5.1.3. Product Benchmarking
    • 8.5.1.4. Strategic Initiatives
  • 8.5.2. TERUMO CORPORATION
    • 8.5.2.1. Overview
    • 8.5.2.2. Financial Performance
    • 8.5.2.3. Product Benchmarking
    • 8.5.2.4. Strategic Initiatives
  • 8.5.3. Kaneka Medical Europe N.V.
    • 8.5.3.1. Overview
    • 8.5.3.2. Financial Performance
    • 8.5.3.3. Product Benchmarking
    • 8.5.3.4. Strategic Initiatives
  • 8.5.4. Stryker
    • 8.5.4.1. Overview
    • 8.5.4.2. Financial Performance
    • 8.5.4.3. Product Benchmarking
    • 8.5.4.4. Strategic Initiatives
  • 8.5.5. Lepu Medical Technology (Beijing) Co.,Ltd
    • 8.5.5.1. Overview
    • 8.5.5.2. Financial Performance
    • 8.5.5.3. Product Benchmarking
    • 8.5.5.4. Strategic Initiatives
  • 8.5.6. Balt
    • 8.5.6.1. Overview
    • 8.5.6.2. Financial Performance
    • 8.5.6.3. Product Benchmarking
    • 8.5.6.4. Strategic Initiatives
  • 8.5.7. NeuroSafe Medical Co., Ltd.
    • 8.5.7.1. Overview
    • 8.5.7.2. Financial Performance
    • 8.5.7.3. Product Benchmarking
    • 8.5.7.4. Strategic Initiatives
  • 8.5.8. Johnson & Johnson
    • 8.5.8.1. Overview
    • 8.5.8.2. Financial Performance
    • 8.5.8.3. Product Benchmarking
    • 8.5.8.4. Strategic Initiatives
  • 8.5.9. Boston Scientific Corporation
    • 8.5.9.1. Overview
    • 8.5.9.2. Financial Performance
    • 8.5.9.3. Product Benchmarking
    • 8.5.9.4. Strategic Initiatives
  • 8.5.10. Medtronic
    • 8.5.10.1. Overview
    • 8.5.10.2. Financial Performance
    • 8.5.10.3. Product Benchmarking
    • 8.5.10.4. Strategic Initiatives